Quantcast
Last updated on April 18, 2014 at 6:46 EDT
US Honey Producers Concerned About Sweetened Substitutes

US Honey Producers Concerned About Sweetened Substitutes

Lawrence LeBlond for redOrbit.com - Your Universe Online Honey is an important food staple, with more than 400 million pounds being consumed annually in the US. However, less than half of this amount – 149 million pounds – actually came...

Latest FDA Stories

2014-04-17 23:14:05

On March 26, the FDA announced the recall of Bella Vi products by Pure Edge Nutrition because they contain undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for weight loss dietary supplements. As the FDA...

2014-04-17 23:10:13

Drehsen claims excellent results in past procedures using stem cell techniques. St. Petersburg, FL (PRWEB) April 17, 2014 One of the most respected plastic surgeons in America is encouraging the FDA to move forward on approval of stem-cell based therapies — inspired in part by Matthew McConaughey's recent Oscar win for the film Dallas Buyers Club. In the film, McConaughey portrayed Ron Woodroof, who fought the Food and Drug Administration over his use and distribution of unapproved...

2014-04-17 08:27:44

Potential to Provide Needed Breathing Support for Patients with Neuromuscular Diseases and Non-Oxygen Dependent Respiratory Diseases IRVINE, Calif., April 17, 2014 /PRNewswire/ -- Breathe Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the fifth 510(k) clearance for its Non-Invasive Open Ventilation (NIOV) System, allowing its use with compressed air supply for non-oxygen dependent patients. The previous four FDA clearances cover the...

2014-04-16 23:17:29

Device manufacturers understand that they must answer the two key design verification and validation questions: did they make the product right and did they make the right product? Learn proven tactics and tools to develop a strong statistical methods program — and a thorough understanding of what FDA auditors look for when they come for an inspection. Falls Church, VA (PRWEB) April 16, 2014 Sample Size Considerations for Verification and Validation: Tools to Safely Speed Your Device to...

2014-04-16 23:16:23

KRS Global Biotechnology, Inc. a specialty pharmacy preparing drugs no longer commercially available or in short supply announces today that they have become a registered Outsourcing Facility under the new Compounding Quality Act. Boca Raton, FL (PRWEB) April 16, 2014 KRS Global Biotechnology, Inc. is pleased to announce that it has been recognized as a registered 503B Large-scale sterile compounding “Outsourcing Facility” by the Food & Drug Administration (FDA) under the Drug...

2014-04-16 16:30:05

CHARLOTTE, N.C., April 16, 2014 /PRNewswire/ -- High manufacturer pricing for most branded diabetic testing products and the recent reduction in insurance reimbursement rates have coupled to reduce retailer and provider margins. To provide retailers serving the more than 25 million Americans with diabetes with a new solution, UniStrip Technologies introduces its first generic blood glucose test strip for use in LifeScan's® OneTouch® Ultra family of meters. Developed and tested...

2014-04-16 12:29:46

CHESTERFIELD, Mo., April 16, 2014 /PRNewswire/ -- Amid the FDA and ASHP announced shortages of unapproved Neostigmine Methylsulfate Injection; Eclat Pharmaceuticals is effectively ending the shortages with BLOXIVERZ®, the only FDA-approved Neostigmine Methylsulfate Injection. http://photos.prnewswire.com/prnvar/20140416/74458 BLOXIVERZ is available in two dosage strengths, 0.5 mg/mL and 1 mg/mL, in 10 mL multiple dose vials. All other Neostigmine Methylsulfate Injections are not...

2014-04-15 23:15:08

National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) April 15, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced today the scheduling of a key court hearing involving litigation* containing allegations that the anti-cholesterol medication Lipitor may cause patients to develop diabetes....

2014-04-15 23:15:02

The FDA advised consumers on April 11, not to use Infinity because it contains a hidden drug ingredient, sibutramine. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for weight loss products. On April 11, the US FDA advised...

2014-04-15 23:14:13

Beginning on Sept. 24, 2014, a unique device identifier (UDI) must be added to Class III medical devices distributed in the US. Devicemakers need to understand what UDI is, who it applies to, what the exceptions to the rule are, what deadlines must be meet, what UDI issuing agencies are and how to work with them. Falls Church, VA (PRWEB) April 15, 2014 The FDAnews UDI Compliance Kit **FDAnews Publication** http://www.fdanews.com/UDIkit Beginning on Sept. 24, 2014, a unique device...